UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054932 |
|---|---|
| Receipt number | R000062738 |
| Scientific Title | Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study. |
| Date of disclosure of the study information | 2024/07/11 |
| Last modified on | 2025/01/09 09:08:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study.
Acronym
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Healthy Adults.
Scientific Title
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study.
Scientific Title:Acronym
Effects of Ingestion of Lactic Acid Bacteria on Subjective Physical Symptoms in Healthy Adults.
Region
| Japan |
Condition
Condition
Healthy adult
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To prove the clinical benefits of lactic acid bacteria intake on subjective physical symptoms in healthy adults.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Subjective symptoms of physical conditions
Key secondary outcomes
Immunological functions
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Daily ingestion of powdered lactic acid bacteria for 16 weeks.
Interventions/Control_2
Daily ingestion of placebo powder for 16 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Subjects who are between the ages of 18 and 64 years old.
Key exclusion criteria
1. Subjects with serious cancer, respiratory, hepatic, renal, cardiac, lung, gastrointestinal, blood, endocrine or metabolic diseases, and/or with serious medical history of those disease.
2. Subjects who have any autoimmune disease.
3. Subjects at risk of allergic reactions to drugs or foods.
4. Pregnant or breastfeeding women or women who expect to become pregnant during this study.
5. Subjects whose BMI is >=30 kg/m2.
6. Heavy smokers, alcoholics or subjects with a disordered lifestyle.
7. Subjects who regularly take medications that affect immune function for more than 1 day per week.
8. Subjects who are at risk of having allergic reactions during this study.
9. Subjects who regularly consume foods that affect immune function.
10. Subjects who have donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks (men and women), or blood components within 2 weeks (men and women), prior to this study.
11. Subjects who were vaccinated within 4 weeks prior to this study.
12. Subjects who are ineligible based on the judgement of the principal investigator.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Naoyuki |
| Middle name | |
| Last name | HONMA |
Organization
Hokkaido Information University
Division name
Department of Medical Management and Informatics
Zip code
069-8585
Address
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
TEL
011-385-4430
hisc-acad.res@s.do-johodai.ac.jp
Public contact
Name of contact person
| 1st name | Naoyuki |
| Middle name | |
| Last name | HONMA |
Organization
Hokkaido Information University
Division name
Health Information Science Center
Zip code
069-8585
Address
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
TEL
011-385-4430
Homepage URL
hisc-acad.res@s.do-johodai.ac.jp
Sponsor or person
Institute
Hokkaido Information University
Institute
Department
Personal name
Funding Source
Organization
Morinaga Milk Industry Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Department of Nutritional Sciences for Well-being, Faculty of Health Sciences for Welfare, Kansai University of Welfare Sciences
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The ethics committee of Hokkaido Information University
Address
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
Tel
011-385-4411
soumu@do-johodai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
北海道情報大学 保健センター（北海道）
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 07 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2024 | Year | 06 | Month | 19 | Day |
Date of IRB
| 2024 | Year | 06 | Month | 19 | Day |
Anticipated trial start date
| 2024 | Year | 07 | Month | 25 | Day |
Last follow-up date
| 2025 | Year | 04 | Month | 05 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2024 | Year | 07 | Month | 11 | Day |
Last modified on
| 2025 | Year | 01 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062738
